Overview

Hyperalgesia, Persistent Pain, and Fentanyl Dosing in On-Pump Coronary Artery Bypass Grafting

Status:
Completed
Trial end date:
2021-01-09
Target enrollment:
Participant gender:
Summary
Randomized, double-blinded, three arm study in adult patients undergoing first time coronary artery bypass grafting (CABG) surgery with median sternotomy. The investigators will examine the effects of three fentanyl dosing schemes (high-dose bolus, low-dose bolus, continuous dose) on the area of hyperalgesia and allodynia at 24 and 48h as well as on persisting pain at 3, 6, and 12 months. Additionally, the investigators will measure fentanyl concentrations throughout anesthesia.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Ghent
Collaborator:
University Hospital, Basel, Switzerland
Treatments:
Fentanyl